5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial-Reference-Cited by-同舟云学术

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

Published:2015-12-10 Issue:1 Volume:155 Page:117-126
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Del Mastro Lucia,Levaggi Alessia,Michelotti Andrea,Cavazzini Giovanna,Adami Francesca,Scotto Tiziana,Piras Margherita,Danese Saverio,Garrone Ornella,Durando Antonio,Accortanzo Valeria,Bighin Claudia,Miglietta Loredana,Pastorino Simona,Pronzato Paolo,Castiglione Federico,Landucci Elisabetta,Conte PierFranco,Bruzzi Paolo

Funder

partial grant from Bristol Myers Squibb

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3655-1.pdf

Reference22 articles.

1. Holmes FA, Walters RS, Theriault R, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797–1805

2. Gianni L, Munzone E, Capri G, Villani F, Spreafico C, Tarenzi E, Fulfaro F, Caraceni A, Martini C, Laffranchi A et al (1995) Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst 87:1169–1175

3. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni A, Martini C et al (1995) Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13:2688–2699